Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study.
Adamo V, Ricciardi GRR, Giuffrida D, Scandurra G, Russo A, Blasi L, Spadaro P, Iacono C, Soto Parra HJ, Savarino A, Ferraú F, Zerilli F, Verderame F, Butera A, Santangelo C, Franchina V, Caruso M. Adamo V, et al. Among authors: iacono c. Ther Adv Med Oncol. 2019 Dec 19;11:1758835919895755. doi: 10.1177/1758835919895755. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31903098 Free PMC article.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience.
Crispo A, Corradin MT, Giulioni E, Vecchiato A, Del Fiore P, Queirolo P, Spagnolo F, Vanella V, Caracò C, Tosti G, Pennacchioli E, Giudice G, Nacchiero E, Quaglino P, Ribero S, Giordano M, Marussi D, Barruscotti S, Guida M, De Giorgi V, Occelli M, Grosso F, Cairo G, Gatti A, Massa D, Atzori L, Calvani N, Fabrizio T, Mastrangelo G, Toffolutti F, Celentano E, Budroni M, Gandini S, Rossi CR, Testori A, Palmieri G, Ascierto PA; Clinical National Melanoma Registry Study Group at the Italian Melanoma Intergroup. Crispo A, et al. Front Oncol. 2021 Jul 8;11:672797. doi: 10.3389/fonc.2021.672797. eCollection 2021. Front Oncol. 2021. PMID: 34307142 Free PMC article.
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement.
Gori S, Pinto C, Caminiti C, Aprile G, Marchetti P, Perrone F, Di Maio M, Omodeo Salè E, Mancuso A, De Cicco M, Di Costanzo F, Crispino S, Passalacqua R, Merlano M, Zagonel V, Fioretto L, Micallo G, Labianca R, Bordonaro R, Comandone A, Spinsanti S, Iacono C, Nicolis F; AIOM (Italian Medical Oncology Association) and AIOM Foundation. Gori S, et al. Among authors: iacono c. Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582. Tumori. 2016. PMID: 27791235
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates.
Vecchiato A, Mocellin S, Del Fiore P, Tosti G, Ascierto PA, Corradin MT, De Giorgi V, Giudice G, Queirolo P, Ferreli C, Occelli M, Giordano M, Trevisan G, Mascheroni L, Testori A, Spina R, Buja A, Cavallin F, Caracò C, Sommariva A, Rossi CR; Clinical National Melanoma Registry Study Group at the Italian Melanoma Intergroup (IMI). Vecchiato A, et al. BMC Cancer. 2021 Jan 5;21(1):8. doi: 10.1186/s12885-020-07705-4. BMC Cancer. 2021. PMID: 33402122 Free PMC article.
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
Tropea S, Del Fiore P, Maurichi A, Patuzzo R, Santinami M, Ribero S, Quaglino P, Caliendo V, Borgognoni L, Sestini S, Giudice G, Nacchiero E, Caracò C, Cordova A, Solari N, Piazzalunga D, Tauceri F, Carcoforo P, Lombardo M, Cavallari S, Mocellin S; Italian Melanoma Intergroup (IMI). Tropea S, et al. BMC Cancer. 2022 Jun 3;22(1):610. doi: 10.1186/s12885-022-09705-y. BMC Cancer. 2022. PMID: 35659273 Free PMC article.
Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients.
Passalacqua R, Caminiti C, Campione F, Diodati F, Todeschini R, Bisagni G, Labianca R, Dalla Chiesa M, Bracci R, Aragona M, Artioli F, Cavanna L, Masina A, De Falco F, Marzocchini B, Iacono C, Contu A, Di Costanzo F, Bertetto O, Annunziata MA. Passalacqua R, et al. Among authors: iacono c. J Clin Oncol. 2009 Apr 10;27(11):1794-9. doi: 10.1200/JCO.2007.15.0615. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273715 Clinical Trial.
250 results